| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 5 | |
| #2 | WIPO (World Intellectual Property Organization) | 5 | |
| #3 | Canada | 4 | |
| #4 | EPO (European Patent Office) | 3 | |
| #5 | Italy | 3 | |
| #6 | China | 2 | |
| #7 | Israel | 2 | |
| #8 | Hong Kong | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Peptides | |
| #5 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Bordignon Claudio | 12 |
| #2 | Traversari Catia | 10 |
| #3 | Mavilio Fulvio | 7 |
| #4 | Tanzarella Silvia | 5 |
| #5 | Russo Vincenzo | 4 |
| #6 | Vincenzo Russo | 1 |
| #7 | Catia Traversari | 1 |
| #8 | Bordignon C | 1 |
| #9 | Parise Flavia | 1 |
| #10 | Ferrari Stefano | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO0073415A2 | A method for the transfer of antigens to dendritic cells | |
| IL146605D0 | Immunogenic peptides derived from mage and the use thereof | |
| AU4037299A | Genetically-modified fibroblasts and the use thereof | |
| WO9934006A2 | A method for the positive selection of cd4+ t-lymphocytes transduced with anti-hiv genes | |
| WO9925814A1 | Genetically-modified myogenic progenitors and their use in cell and gene therapy |